Dysregulation and Overexpression of HMGA2 in Myelofibrosis with Myeloid Metaplasia

Genes Chromosomes and Cancer

Volumn 39, Issue 1, 2004, Pages 82-87

  Andrieux, Joris ^a,b   Demory, Jean Loup ^c   Dupriez, Brigitte ^d   Quief, Sabine ^a   Plantier, Isabelle ^e   Roumier, Christophe ^a,b   Bauters, Francis ^b   Laï, Jean Luc ^a,b   Kerckaert, Jean Pierre ^a  

^a Institut de Recherche sur le Cancer de Lille   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ CATHOLIQUE DE LILLE   (France)

^d Centre Hospitalier de LENS   (France)

^e CENTRE HOSPITALIER DE ROUBAIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CHROMOSOME 12; CHROMOSOME 12Q; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; MONONUCLEAR CELL; MYELOFIBROSIS; MYELOID METAPLASIA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BACTERIA (MICROORGANISMS);

EID: 0344420249     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10297     Document Type: Article

References (29)

1. Anand A, Chada K. 2000. In vivo modulation of Hmgic reduces obesity. Nat Genet 24:377-380.
2. Andrieux J, Demory JL, Morel P, Plantier I, Dupriez B, Caulier MT, Bauters F, Laï JL. 2002. Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia. Cancer Genet Cytogenet 137:68-71.
3. Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Veremowicz S, Morton CC, Chada K. 1995. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 82:57-65.
4. Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, Waldmann TA, Azimi N, Croce CM, Fusco A. 2001. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway, Proc Natl Acad Sci USA 98:7970-7975.
5. Barosi G, Ambrosetti A, Finelli C, Grossi A, Leoni P, Liberato NL, Petti MC, Pogliani E, Ricetti M, Rupoli S, Visani G, Tura S. 1999. The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 104:730-737.
6. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, Marchetti M, Frassoni F. 2001. Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 98:3249-3255.
7. Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H, Santoro M, Croce CM, Fusco A. 1999. The expression of a truncated HMG1-C gene induces gigantism associated with lipomatosis. Cancer Res 59:4793-4797.
8. Berlingieri MT, Pierantoni GM, Giancotti V, Santoro M, Fusco A. 2002. Thyroid cell transformation requires the expression of the HMGA1 proteins. Oncogene 21:2971-2980.
9. Borrego S, Antinolo G, Martin-Noya A, Parody R. 1993. Translocation (8:12) in a patient with agnogenic myeloid metaplasia. Cancer Genet Cytogenet 71:183-184.
10. Broberg K, Tallini G, Hoglund M, Lindstrand A, Toksvig-Larsen S, Mertens F. 2001. The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia. Mod Pathol 14:311-317.
11. Demory JL, Dupriez B, Fenaux P, Laï JL, Beuscart R, Jouet JP, Deminatti M, Bauters F. 1988. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood 72:855-859.
12. Diana F, Sgarra R, Manfioletti G, Rustighi A, Poletto D, Sciortino MT, Mastino A, Giancotti V. 2001. A link between apoptosis and degree of phosphorylation of high mobility group Ala protein in leukemic cells. J Biol Chem 276:11354-11361.
13. Dupriez B, Morel P, Demory JL, Laï JL, Simon M, Plantier I, Bauters F. 2002. Prognostic factors in agnogenic myeloid metaplasia: A report on 195 cases with a new scoring system. Blood 88:1013-1018.
14. Gattas GJ, Quade BJ, Nowak RA, Morton CC. 1999. HMGIC expression in human adult and fetal tissues and in uterine leiomyomata. Genes Chromosomes Cancer 25:316-322.
15. Kottickal LV, Sarada B, Ashar H, Chada K, Nagarajan L. 1998. Preferential expression of HMGI-C isoforms lacking the acidic carboxy terminal in human leukemia. Biochem Biophys Res Commun 242:452-456.
16. Mantovani F, Covaceuszach S, Rustighi A, Sgarra R, Heath C, Goodwin GH, Manfioletti G. 1998. NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res 26:1433-1439.
17. ISCN. 1996. An international system for human cytogenetic nomenclature. Mitelman F, editor. Basel, Switzerland: S. Karger.
18. Pierantoni GM, Santulli B, Caliendo I. Pentimalli F, Chiappetta G, Zanesi N, Santoro M, Bulrich F, Fusco A. 2003. HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. Int J Oncol 23:363-367.
19. Przepiorka D, Bryant E, Kidd P. 1988: Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion. Cancer Genet Cytogenet 30:139-144.
20. Reilly JT. 1998. Pathogenesis and management of idiopathic myelofibrosis. Baillieres Clin Haematol 11:751-767.
21. Reilly JT. 2002. Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis. Acta Haematol 108:113-119.
22. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A. 1997. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: A study of 106 cases. Br J Haematol 98:96-102.
23. Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J. 1997. HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 26:603-607.
24. Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V, Bullerdiek J, Fusco A. 2000. A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 119:70-73.
25. Sreekantaiah C. 1998. The cytogenetic and molecular characterization of benign and malignant soft tissue tumors. Cytogenet Cell Genet 82:13-29.
26. Tefferi A. 2000. Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255-1265.
27. Van Slyck EJ, Weiss L, Dully M. 1970. Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood 36:729-735.
28. Ward HP, Block MH. 1971. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50:357-420.
29. Zhou X, Benson KF, Ashar HR, Chada K. 1995. Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774.